Israel's plan to parlay its COVID-19 vaccination drive into an exit from the pandemic next month hangs in the balance as new variants of the virus have spurred an increase in infections, a senior official said on Wednesday.
Highly infectious foreign variants are currently flooding Israeli hospitals with serious cases and the newly developed vaccines have yet to be proven fully effective against them, Deputy Health Minister Yoav Kisch said.
4 View gallery
Woman walks through an abandoned Mahane Yehuda market in Jerusalem during COVID-19 pandemic
(Photo: Gil Yochanan)
Israel currently leads the world on per capita vaccinations, having inoculated about 30% of its population of nine million with at least one dose.
"We are in a war with very low intelligence [about the enemy]," Kisch, a former fighter pilot, told Reuters. "That means that things are changing as we go. The enemy is using different tactics and different methods that we are not fully aware of."
Israel began vaccinating high-risk groups on Dec. 19 in what Prime Minister Benjamin Netanyahu predicted would provide them with full protection by the end of this month and enable the economy to begin reopening in February.
But despite expanded eligibility criteria for the Pfizer Inc. vaccines and the imposition of a third national lockdown, infections and deaths are surging.
'OPTIMISTIC'
Israel's projections of a vaccine-fuelled turnaround last week proved false, Kisch said. Now it is hoping to see in the coming two weeks a reduction in morbidity as well as solid research data showing that the vaccines defeat the variants.
4 View gallery
Health worker administers COVID-19 vaccine at a Maccabi Healthcare Services vaccination center in Giv'atayim
(Photo: AFP)
"We are optimistic because, as of now, the knowledge regarding this vaccine is [that it is] effective against them," Kisch said.
If that is correct, that means a delay of only two to four weeks in Israel's planned exit from the pandemic, he said. If not, Israel could be facing a further delay of six to eight months.
"We'll have to wait for a new development of a vaccine that will give the answer against this mutation," Kisch said.
Asked what hospitalization data would give Israel cause for hope, Kisch said it had not set a threshold. But if the 2% rate of serious cases among COVID-19 patients could be halved, that would "make a huge difference".
4 View gallery
Prime Minister Benjamin Netanyahu during a visit to a Jerusalem health clinic administering COVID-19 vaccine
(Photo: Emille Selman)
Netanyahu is up for re-election on March 23. His Likud party messaging suggests that the coronavirus strategy is central to the campaign. Yet Kisch, a Likud lawmaker, sounded circumspect.
"We are doing the best that we can against corona, with or without elections, with or without politics," he said.